{"transactions":[{"id":3956969,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":167297,"kind":"person","name":"Bahagon Yossi","position":1,"cik":"0001697541","reported_name":"Bahagon Yossi","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Common Stock","published_at":"2018-04-25T20:06:05.000Z","date":"2018-04-23","kind":"grant","acquired":true,"shares":3335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for part of the first quarter of 2018, until his retirement from the board, in the amount of $5,138.89."}],"balance_after":13957,"source":{"system":"sec-edgar","filing":"0001144204-18-022371","document":"tv491860_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420418022371/tv491860_4.xml","form_type":"4"}},{"id":4103947,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":167297,"kind":"person","name":"Bahagon Yossi","position":1,"cik":"0001697541","reported_name":"Bahagon Yossi","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-08T21:08:38.000Z","date":"2018-01-04","kind":"grant","acquired":true,"shares":3983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the fourth quarter of 2017 in the amount of $6,250."}],"balance_after":10622,"source":{"system":"sec-edgar","filing":"0001144204-18-001294","document":"tv482691_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420418001294/tv482691_4.xml","form_type":"4"}},{"id":4161789,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":167297,"kind":"person","name":"Bahagon Yossi","position":1,"cik":"0001697541","reported_name":"Bahagon Yossi","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase Common Stock","published_at":"2017-11-15T21:05:44.000Z","date":"2017-11-13","kind":"other","acquired":false,"shares":892858,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On November 13, 2017, DarioHealth Corp. (the \"Company\") and OurCrowd Digital Health L.P. (\"OurCrowd\") entered into a warrant exchange agreement whereby OurCrowd agreed to surrender a warrant to purchase 892,858 shares of the Company's common stock in exchange for 496,031 restricted shares of the Company's common stock. The amounts shown represent the beneficial ownership or the issuer's securities by OurCrowd, which may be deemed attributable to Mr. Bahagon because Mr. Bahagon is a Managing Partner of OurCrowd. Mr. Bahagon disclaims beneficial ownership of the securities set forth herein except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":3.5,"exercise_date":"2017-07-10","expiration_date":"2022-01-09","underlying":"Common Stock","underlying_shares":892858},"source":{"system":"sec-edgar","filing":"0001144204-17-059419","document":"tv479694_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420417059419/tv479694_form4.xml","form_type":"4"}},{"id":4161788,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":167297,"kind":"person","name":"Bahagon Yossi","position":1,"cik":"0001697541","reported_name":"Bahagon Yossi","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-15T21:05:44.000Z","date":"2017-11-13","kind":"grant","acquired":true,"shares":496031,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 13, 2017, DarioHealth Corp. (the \"Company\") and OurCrowd Digital Health L.P. (\"OurCrowd\") entered into a warrant exchange agreement whereby OurCrowd agreed to surrender a warrant to purchase 892,858 shares of the Company's common stock in exchange for 496,031 restricted shares of the Company's common stock. The amounts shown represent the beneficial ownership or the issuer's securities by OurCrowd, which may be deemed attributable to Mr. Bahagon because Mr. Bahagon is a Managing Partner of OurCrowd. Mr. Bahagon disclaims beneficial ownership of the securities set forth herein except to the extent of their pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 13, 2017, DarioHealth Corp. (the \"Company\") and OurCrowd Digital Health L.P. (\"OurCrowd\") entered into a warrant exchange agreement whereby OurCrowd agreed to surrender a warrant to purchase 892,858 shares of the Company's common stock in exchange for 496,031 restricted shares of the Company's common stock. The amounts shown represent the beneficial ownership or the issuer's securities by OurCrowd, which may be deemed attributable to Mr. Bahagon because Mr. Bahagon is a Managing Partner of OurCrowd. Mr. Bahagon disclaims beneficial ownership of the securities set forth herein except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On November 13, 2017, DarioHealth Corp. (the \"Company\") and OurCrowd Digital Health L.P. (\"OurCrowd\") entered into a warrant exchange agreement whereby OurCrowd agreed to surrender a warrant to purchase 892,858 shares of the Company's common stock in exchange for 496,031 restricted shares of the Company's common stock. The amounts shown represent the beneficial ownership or the issuer's securities by OurCrowd, which may be deemed attributable to Mr. Bahagon because Mr. Bahagon is a Managing Partner of OurCrowd. Mr. Bahagon disclaims beneficial ownership of the securities set forth herein except to the extent of their pecuniary interest therein."}],"balance_after":1388889,"source":{"system":"sec-edgar","filing":"0001144204-17-059419","document":"tv479694_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420417059419/tv479694_form4.xml","form_type":"4"}},{"id":4180536,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":167297,"kind":"person","name":"Bahagon Yossi","position":1,"cik":"0001697541","reported_name":"Bahagon Yossi","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-25T20:05:42.000Z","date":"2017-10-23","kind":"grant","acquired":true,"shares":3367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2017 in the amount of $6,250."}],"balance_after":6639,"source":{"system":"sec-edgar","filing":"0001144204-17-054092","document":"tv477604_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420417054092/tv477604_4.xml","form_type":"4"}},{"id":4258894,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":167297,"kind":"person","name":"Bahagon Yossi","position":1,"cik":"0001697541","reported_name":"Bahagon Yossi","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-07-11T20:05:14.000Z","date":"2017-07-10","kind":"grant","acquired":true,"shares":2703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the second quarter of 2017 in the amount of $6,250."}],"balance_after":3272,"source":{"system":"sec-edgar","filing":"0001144204-17-036435","document":"v470575_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420417036435/v470575_4.xml","form_type":"4"}},{"id":4351312,"issuer":{"id":7024,"kind":"organization","name":"DarioHealth Corp.","symbol":"DRIO"},"owners":[{"id":167297,"kind":"person","name":"Bahagon Yossi","position":1,"cik":"0001697541","reported_name":"Bahagon Yossi","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-17T20:16:51.000Z","date":"2017-04-13","kind":"grant","acquired":true,"shares":569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was awarded such securities in exchange for waiving director fees owed for the first quarter of 2017 in the amount of $2,083.33."}],"balance_after":569,"source":{"system":"sec-edgar","filing":"0001144204-17-020711","document":"v464363_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533998/000114420417020711/v464363_4.xml","form_type":"4"}}]}